Cargando…
Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome
BACKGROUND: Brain-derived neurotrophic factor (BDNF) is a well-established neurotrophin that plays a role in the pathophysiology of numerous psychiatric disorders. Many studies have investigated the serum BDNF levels in patients with schizophrenia. However, there are restricted data in the literatur...
Autores principales: | Akyol, Esra Soydaş, Albayrak, Yakup, Beyazyüz, Murat, Aksoy, Nurkan, Kuloglu, Murat, Hashimoto, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386764/ https://www.ncbi.nlm.nih.gov/pubmed/25848285 http://dx.doi.org/10.2147/NDT.S79444 |
Ejemplares similares
-
Neurological soft signs might be endophenotype candidates for patients with deficit syndrome schizophrenia
por: Albayrak, Yakup, et al.
Publicado: (2015) -
Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study
por: Beyazyüz, Murat, et al.
Publicado: (2016) -
Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo
por: Yanik, M Emin, et al.
Publicado: (2014) -
Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
por: Ünsal, Cüneyt, et al.
Publicado: (2013) -
Increased serum dehydroepiandrosterone sulfate in the first episode but not in subsequent episodes in male patients with schizophrenia
por: Beyazyüz, Murat, et al.
Publicado: (2014)